May 11, 2015 — Provision Healthcare has signed a joint agreement with the Tianjin Taishan Cancer Hospital (International Personalized Cancer Center, “IPCC”) in northern China to build the first and only proton therapy center in the free trade zone. The agreement will also develop a training facility for medical providers as part of Provision’s global expansion strategy.
The $100 million center will be jointly owned and operated by Provision and Tianjin Hospital and named the TAEA Sino-US Proton Treatment and Research Center. ProNova Solutions, Provision’s research and development (R&D) and manufacturing business, will manufacture and outfit the center’s three treatment rooms with its SC360 proton treatment system. The project is scheduled for completion in early 2018.
Proton therapy uses a single beam of high-energy protons to precisely target a tumor with limited exposure to surrounding healthy tissues. Proton therapy is used to treat a variety of cancer types including prostate, breast, lung, head and neck, pediatric cancer and Hodgkin’s lymphoma.
The venture will include a research capability for conducting clinical trials focused on further development of proton therapy in northern China. Additionally, the partners will develop and build a nearby training center to educate medical personnel as the use of proton therapy expands across the country.
“As the name indicates, Tianjin Taishan Hospital (IPCC) strives to provide personalized cancer treatment,” said Xishan Hao, M.D., president of the Chinese Anti-Cancer Association, honorary president of Tianjin Medical University and Tianjin Medical University Cancer Institute and Hospital, director of the Tianjin Cancer Institute. “ProNova’s advanced technology will help Tianjin Taishan Hospital become the first provider for proton therapy in a free trade zone of China. The network of proton therapy centers that Provision has created will bring Taishan to the front row of global cancer research.”
The proton center’s three treatment rooms will include two 360-degree rotation gantrys and one fixed beam system, and Provision will be responsible for operation and maintenance of the equipment. Provision will be involved in design and development of the project as well as management of patient services.
For more information: www.provisionha.com
March 28, 2024 
